Quick Heal Technologies Limited announces 9MFY21 Results

  • Revenue at ₹2,278 mln up 2.6% Y-o-Y
  • EBITDA at ₹877 mln up 5% Y-o-Y with EBITDA margin of 38.5%
  • PAT at ₹673 mln up 1% Y-o-Y
  • Continues to be a debt free company

Pune, February 3, 2021: Quick Heal Technologies Limited (“Quick Heal”), one of the leading providers of cybersecurity and data protection solutions to consumers, businesses and Government, reported its reviewed and unaudited results for the quarter and nine months ended 31th December 2020.

Consolidated Financial Highlights

Particulars
( million)

Q3FY21

Q3FY20

Y-o-Y Change

9MFY21

9MFY20

Y-o-Y Change

Revenue

698.75

657.07

6.34%

2,277.50

2,218.84

2.64%

EBITDA

164.63

232.25

-29.12%

876.85

838.07

4.63%

EBITDA Margin

23.56%

35.35%

-1179bps

38.50%

37.77%

73bps

PAT

134.61

177.85

-24.31%

672.54

664.18

1.26%

PAT Margin

19.26%

27.07%

-780bps

29.53%

29.93%

-40bps

Dr. Kailash Katkar, Managing Director & Chief Executive Officer, Quick Heal Technologies Limited, said; “We delivered good revenue performance during the third quarter as the Indian economy slowly started recovering from the Covid-19 pandemic. On the R&D front, with the appointment of industry veterans like Sanjay Agrawal and Bibhuti Kar, we have accelerated new product development efforts to strengthen our enterprise business under ‘Seqrite’. Furthermore, we recently announced additional investment in Israel based company – L7 Defense, reiterating our commitment to invest in disruptive technologies that will shape the future of cybersecurity while supporting innovative start-ups. With economy slowly recovering and increase in cybersecurity awareness, we are confident to end the year on a positive note.”

Mr. Nitin Kulkarni, Chief Financial Officer, Quick Heal Technologies Limited, added; “We have performed better in what traditionally remains a weak quarter for us with quarterly revenue growing 6.3% YoY basis. With economy slowly recovering, we have increased our investments in advertisements and continued focus in R&D innovations have affected our margins. Our balance sheet remains strong with zero debt and a cash and cash equivalents balance of ₹4,787 mln.”

Segmental Performance for nine months ended 31st December 2020

  • Retail segment revenue at ₹2,038 million compared to ₹1,876 in 9MFY20. Retail segment contributed 81.5% to total revenue in 9MFY21
  • Enterprise and Government segment revenue at ₹464 million compared to ₹468 mln in 9MFY20. Enterprise segment contributed 18.5% to total revenue in 9MFY21

Key updates:

  • Quick Heal Technologies signed a definitive agreement to make an additional strategic investment of USD 2 million in L7 Defense, an Israel based cybersecurity start-up. The investment enables Quick Heal to expand its range of enterprise solutions under the ‘Seqrite’ umbrella and introduce L7’s flagship products in market stronghold of India as well as other regions in APAC and EMEA.

About Quick Heal Technologies Limited

Quick Heal Technologies Limited is one of the leading providers of IT Security and Data Protection Solutions with a strong footprint in India and an evolving global presence. Incorporated in the year 1995, with a registered office in Pune, it is a player in cybersecurity with presence in B2B, B2G and B2C segments and multiple product categories – endpoints, network, data and mobility.

It helps in simplifying security by delivering best-in-class protection against advanced cyber-threats to millions of its customers and enterprises. Quick Heal’s portfolio includes solutions under the widely recognized brand names ‘Quick Heal’ and ‘Seqrite’ across various operating systems and devices.

For more information about the Company, please visit our website www.quickheal.co.in

Safe Harbor Statement

This document may contain forward-looking statements about Quick Heal Technologies Limited, which are based on the beliefs, opinions, and expectations of the company’s management as the date of this press release and the companies do not assume any obligation to update their forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change. These statements are not the guarantees of future performance and involve risks and uncertainties that are difficult to predict. Consequently, readers should not place any undue reliance on such forward-looking statements.

For further details please contact

Company

Quick Heal Technologies Limited

CIN No: L72200MH1995PLC091408

Mr. Akash Gosavi

Email id: akash.gosavi@quickheal.co.in

Tel. No.: +91 020 6681 3287